135 related articles for article (PubMed ID: 17346217)
1. G-coupled protein receptors and breast cancer progression: potential drug targets.
Taborga M; Corcoran KE; Fernandes N; Ramkissoon SH; Rameshwar P
Mini Rev Med Chem; 2007 Mar; 7(3):245-51. PubMed ID: 17346217
[TBL] [Abstract][Full Text] [Related]
2. Neurokinin receptors as potential targets in breast cancer treatment.
Reddy BY; Trzaska KA; Murthy RG; Navarro P; Rameshwar P
Curr Drug Discov Technol; 2008 Mar; 5(1):15-9. PubMed ID: 18537563
[TBL] [Abstract][Full Text] [Related]
3. Functions of CXCL12 and CXCR4 in breast cancer.
Luker KE; Luker GD
Cancer Lett; 2006 Jul; 238(1):30-41. PubMed ID: 16046252
[TBL] [Abstract][Full Text] [Related]
4. Involvement of chemokine receptors in organ-specific metastasis.
Zlotnik A
Contrib Microbiol; 2006; 13():191-199. PubMed ID: 16627966
[TBL] [Abstract][Full Text] [Related]
5. The CXCL12-CXCR4 chemotactic pathway as a target of adjuvant breast cancer therapies.
Epstein RJ
Nat Rev Cancer; 2004 Nov; 4(11):901-9. PubMed ID: 15516962
[TBL] [Abstract][Full Text] [Related]
6. Increased cabbage intake may inhibit metastatic and invasive capacity of breast cancer cells by inhibiting CXCL12(SDF-1 alpha)/CXCR4.
Altundag K; Gundeslioglu O; Altundag O
Med Hypotheses; 2006; 66(3):672. PubMed ID: 16006053
[No Abstract] [Full Text] [Related]
7. The CXCR4/SDF-1 chemokine axis: a potential therapeutic target for bone metastases?
Hirbe AC; Morgan EA; Weilbaecher KN
Curr Pharm Des; 2010; 16(11):1284-90. PubMed ID: 20166978
[TBL] [Abstract][Full Text] [Related]
8. Clinical importance and therapeutic implications of the pivotal CXCL12-CXCR4 (chemokine ligand-receptor) interaction in cancer cell migration.
Arya M; Ahmed H; Silhi N; Williamson M; Patel HR
Tumour Biol; 2007; 28(3):123-31. PubMed ID: 17510563
[TBL] [Abstract][Full Text] [Related]
9. A chemokine, SDF-1/PBSF, and its receptor, CXC chemokine receptor 4, as mediators of hematopoiesis.
Nagasawa T
Int J Hematol; 2000 Dec; 72(4):408-11. PubMed ID: 11197205
[TBL] [Abstract][Full Text] [Related]
10. The role of adhesion molecules and chemokine receptor CXCR4 (CD184) in small cell lung cancer.
Hartmann TN; Burger M; Burger JA
J Biol Regul Homeost Agents; 2004; 18(2):126-30. PubMed ID: 15471215
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic roles and drug target of CXCR4/CXCL12 axis in lung cancer and cancer stem cell.
Wang Z; Sun J; Feng Y; Tian X; Wang B; Zhou Y
Tumour Biol; 2016 Jul; 37(7):8515-28. PubMed ID: 27079871
[TBL] [Abstract][Full Text] [Related]
12. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M
J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4.
Bachelder RE; Wendt MA; Mercurio AM
Cancer Res; 2002 Dec; 62(24):7203-6. PubMed ID: 12499259
[TBL] [Abstract][Full Text] [Related]
14. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.
Darash-Yahana M; Pikarsky E; Abramovitch R; Zeira E; Pal B; Karplus R; Beider K; Avniel S; Kasem S; Galun E; Peled A
FASEB J; 2004 Aug; 18(11):1240-2. PubMed ID: 15180966
[TBL] [Abstract][Full Text] [Related]
15. CXCR4 in breast cancer: oncogenic role and therapeutic targeting.
Xu C; Zhao H; Chen H; Yao Q
Drug Des Devel Ther; 2015; 9():4953-64. PubMed ID: 26356032
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of CXCR4-mediated breast cancer metastasis: a potential role for heparinoids?
Harvey JR; Mellor P; Eldaly H; Lennard TW; Kirby JA; Ali S
Clin Cancer Res; 2007 Mar; 13(5):1562-70. PubMed ID: 17332302
[TBL] [Abstract][Full Text] [Related]
17. The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis.
Wang J; Loberg R; Taichman RS
Cancer Metastasis Rev; 2006 Dec; 25(4):573-87. PubMed ID: 17165132
[TBL] [Abstract][Full Text] [Related]
18. T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer.
Tamamura H; Hori A; Kanzaki N; Hiramatsu K; Mizumoto M; Nakashima H; Yamamoto N; Otaka A; Fujii N
FEBS Lett; 2003 Aug; 550(1-3):79-83. PubMed ID: 12935890
[TBL] [Abstract][Full Text] [Related]
19. Beta-catenin is a promising key factor in the SDF-1/CXCR4 axis on metastasis of pancreatic cancer.
Wang Z; Ma Q
Med Hypotheses; 2007; 69(4):816-20. PubMed ID: 17379424
[TBL] [Abstract][Full Text] [Related]
20. Role of chemokine SDF-1/PBSF and its receptor CXCR4 in blood vessel development.
Nagasawa T
Ann N Y Acad Sci; 2001 Dec; 947():112-5; discussion 115-6. PubMed ID: 11795258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
